NASHUA, N.H., July 27, 2022 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the second quarter ended June 30, 2022, after the market close, and host a conference call at 4:30 PM Eastern Time on August 10, 2022.
August 10, 2022 at 4:30 PM ET
Domestic: 888-506-0062
International: 973-528-0011
Conference ID: 718241
Webcast: https://www.webcaster4.com/Webcast/Page/2879/46166
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com
Investor Inquiries:
iCAD Investor Relations
ir@icadmed.com
Three Stations to Host Interactive Experiences from January 6–11 LAS VEGAS, Jan. 3, 2025 /PRNewswire/…
VANCOUVER, BC, Jan. 3, 2025 /PRNewswire/ - Human In Motion Robotics Inc. (HMR), a leading innovator…
Technology Discovers Antigen-Reactive T Cell Receptors with High Efficiency PHILADELPHIA, Jan. 3, 2025 /PRNewswire/ -- Researchers…
Top EHR Vendors Shine in Multiple Specialties: ModMed, NextGen Healthcare, Netsmart, ClinicMind, Epic, and RXNT…
54 Specialty EHR Vendors Across 17 Categories Mark New Entries in the 2024 Black Book…
Final Short Form Prospectus Accessible on SEDAR+Toronto, Ontario--(Newsfile Corp. - January 3, 2025) - Vitalhub…